Now Reading: Oxford Nanopore Shares Slide as First-Half Revenue Misses Expectations
-
01
Oxford Nanopore Shares Slide as First-Half Revenue Misses Expectations
Oxford Nanopore Shares Slide as First-Half Revenue Misses Expectations
Oxford Nanopore expects first-half revenue of about £116.5 million after weaker trading in China and the Middle East and slower order timing in the Americas.
Oxford Nanopore Technologies has warned that first-half revenue was below management expectations after weaker trading in China, disruption in the Middle East and slower-than-expected order timing in the Americas.
The FTSE 250-listed DNA and RNA sequencing specialist expects first-half 2026 revenue of approximately £116.5 million, representing 12% year-on-year growth at constant currency. China revenue declined 16%, while Middle East revenue fell 14% amid regional disruption.
Why it matters
The update raises execution risk around Oxford Nanopore’s near-term growth trajectory and highlights its exposure to export controls, geopolitical disruption and uneven customer-order timing. Management nevertheless said it expects a materially stronger second half and remains on track to reach adjusted EBITDA breakeven during 2027.
Company: Oxford Nanopore Technologies plc
Ticker: LSE: ONT
Sector: Pharmaceuticals / Biotechnology
UK release time: 13 July 2026, approximately 07:00 BST
Sources: Oxford Nanopore Technologies trading update; London Stock Exchange/RNS; Reuters market reporting.
Post Disclaimer
The following content has been published by Stockmark.IT. All information utilised in the creation of this communication has been gathered from publicly available sources that we consider reliable. Nevertheless, we cannot guarantee the accuracy or completeness of this communication.
This communication is intended solely for informational purposes and should not be construed as an offer, recommendation, solicitation, inducement, or invitation by or on behalf of the Company or any affiliates to engage in any investment activities. The opinions and views expressed by the authors are their own and do not necessarily reflect those of the Company, its affiliates, or any other third party.
The services and products mentioned in this communication may not be suitable for all recipients, by continuing to read this website and its content you agree to the terms of this disclaimer.
Related Posts
Previous Post
Next Post
